Ribavirin Does Not Enhance Hepatitis B Virus Nucleotide Antiviral Activity: A Pilot Study

Clinical and Investigative Medicine · Published 2022-12-31 · DOI 10.25011/cim.v45i4.39274

Authors being retrieved — see the publisher record. https://doi.org/10.25011/cim.v45i4.39274

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2022

Related articles

• Spring 2023: Clinician Investigator Trainee Association of Canada (CITAC) · Clinical and Investigative Medicine · 2023 · Same journal
• New CIM Editor-in-Chief · Clinical and Investigative Medicine · 2024 · Same journal
• AUF1 mitigates retinal ganglion cell apoptosis in glaucoma by regulating the Nrf2/HO-1 pathway · Clinical and Investigative Medicine · 2025 · Same journal
• Training Outcomes and Satisfaction in Canadian MD/PhD and MD/MSc Programs: Findings from a National Survey · Clinical and Investigative Medicine · 2024 · Same journal
• Knowledge Mapping of Inflammasome and Pyroptosis in Stroke: A Bibliometric Analysis (2007-2023) · Clinical and Investigative Medicine · 2023 · Same journal
• Value of serum iron and urine neutrophil gelatinase-associated lipocalin in predicting the mortality of critically ill patients with sepsis · Clinical and Investigative Medicine · 2024 · Same journal
• A longitudinal study of research productivity in McGill University's MD-PhD and Clinician Investigator Program Graduates from 2000 to 2017 · Clinical and Investigative Medicine · 2026 · Same journal
• H19 Promoter DNA Methylation is Lower Among Early Abortion Patients Undergoing IVF Embryo Transfer · Clinical and Investigative Medicine · 2023 · Same journal
• Recommendations for Recovery of the COVID-19 Pandemic-related Diagnostic, Screening, and Procedure Backlog in Ontario: A Survey of Healthcare Leaders · Clinical and Investigative Medicine · 2024 · Same journal
• Hats Off to the CIM Reviewers Of 2022 · Clinical and Investigative Medicine · 2022 · Same journal